Researchers identified changes in two genes that increase the risk of developing Tourette syndrome. The results suggest new targets to study for potential treatments.
Immune cells recognize and react to alpha-synuclein, the protein that builds up in the brains of people with Parkinson’s disease. The finding suggests immune system involvement in the disease.
Researchers identified symptom-causing mutations in people with severe atopic dermatitis, or eczema. The findings suggest a treatment strategy, and trials are being planned.
June 27, 2017 —
Analyzing a rare genetic mutation in a child helped researchers discover how the immune system responds to common cold viruses. The findings may lead to better therapies.
June 27, 2017 —
Yoga was as effective as standard physical therapy for treating moderate to severe chronic low back pain in people in underserved communities.
June 27, 2017 —
Eliminating old or damaged cells that have stopped dividing reduced signs of fatty liver disease in mice. The findings are an important clue for developing treatments.
June 20, 2017 —
Low doses of ketamine didn’t reduce delirium, postoperative pain, or other complications related to major surgeries. The results challenge a common practice.
June 20, 2017 —
Detailed views of two membrane receptors involved in controlling blood glucose reveal new insights into important drug targets for diabetes and obesity.
June 13, 2017 —
Researchers uncovered a key role for intestinal fungi in the liver damage seen in alcoholic liver disease. The findings suggest a potential approach to treating alcoholic liver disease.
June 13, 2017 —
In the lab, novel compounds thwarted bacteria that are resistant to the antibiotic vancomycin. The findings could lead to improved antibiotics.
